![New MHLW Guidance Aims to Facilitate Inclusion of Japanese Participants in Global Clinical Trials](https://industry.pharmafocusamerica.com/slider/1709706434-new-mhlw-guidance.png)
Nectin Therapeutics Ltd a biotechnology company focused on developing innovative immunotherapies and antibody drug conjugates to overcome tumor resistance has announced an exclusive global licensing agreement with Immunome Inc a biotechnology firm dedicated to creating cuttingedge cancer treatments
AC Immune SA a biopharmaceutical company focused on neurodegenerative diseases has announced that its candidate for active immunotherapy ACI targeting the pathological
M Pharmaceuticals a subsidiary of Acino has entered into an exclusive licensing and distribution agreement with LG Chem Ltd a prominent life sciences company based in South Korea
Inimmune a clinicalstage biotech company dedicated to advancing novel immunotherapies vaccines and adjuvants has announced the launch of its Phase clinical trial for INI This trial marking
Eclipse Bioinnovations Inc has launched its cuttingedge eMERGE platform designed to revolutionize the development of RNAbased therapeutics This advanced platform provides a complete solution
Orange Grove Bio a leading biopharmaceutical company has teamed up with the University of Chicagos Polsky Center for Entrepreneurship and Innovation to drive the commercialization
Actinium Pharmaceuticals Inc a leader in the development of Antibody Radiation Conjugates and other targeted radiotherapies today announced the FDA clearance of an Investigational New Drug application to study IomabACT for targeted
Cellectis a clinicalstage biotechnology company using its pioneering TALEN genome
Ipsen and Day One Biopharmaceuticals today announced a global partnership agreement outside the United States for tovorafenib in GBG the most common form of childhood brain cancer and any future indications developed
ITF Therapeutics LLC the USbased rare disease commercial arm of Italfarmaco today announced the US commercial launch of DUVYZAT givinostat a histone deacetylase inhibitor for the treatment of patients
Boston, MA, USA
Boston, MA, USA
jakarta barat, Indonesia
Brussels, Belgium
Boston, USA
London, UK
Boston, MA, USA
Pennsylvania, USA
Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus America, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Tissue engineering and cell therapy are rapidly developing directions of medicine which is focused on the restoration of injured tissues and organs This branch of medicine employs the bodys inherent mechanisms to rebuild or restore damaged
It is crucial to learn that AMR is a relatively recent health concern mainly undermining the efficacy of required drugs globally Earlier the drugs that fought against bacteria
MRNA technology is an example of one of the basic irreversible shifts in medicine as the curative business model for diseases There is a kind of RNA that is responsible for transferring the information obtained from DNA
Pharmaceutical distribution is a vital component of the drug delivery system it involves getting the medicines to the intended patients on time and without unnecessary complications It is a carefully designed procedure
Opioid crisis is an unprecedented public health calamity that has blighted numerous societies worldwide although predominantly those in America This crisis is characterized by the abuse of both Rx and overthecounter opioids causing
The pharmaceutical industry is experiencing a transformative shift with the integration of imaging informatics which combines advanced imaging techniques with data analytics to improve drug discovery
Singlecell RNA sequencing scRNAseq has emerged as a powerful technique to decipher tissue composition at the singlecell level and to inform on disease mechanisms tumor heterogeneity and the state of the immune microenvironment Although multiple methods for the computational analysis of scRNAseq data exist their application in a clinical setting demands
BioPhy has introduced an innovative AI operating system aimed at significantly expediting the identification and development of promising drug candidates
Determining the ability of a target to bind to a drug with high affinity to modulate its function with a therapeutic benefit could be termed Druggability It needs a nontrivial amount of time financial investment
Navigating the complex and dynamic gene therapy regulatory landscape has been a persistent challenge for developers and manufacturers
Antibody drug conjugates ADCs are innovative modalities to deliver chemotherapeutics to specifically targeted populations of cancer cells
Clinical trials form the backbone of pharmaceutical development acting as the proving ground where the safety and efficacy of novel medical interventions are thoroughly evaluated
A number of exciting innovations have begun to gain the attention of companies within the pharmaceutical sector Artificial intelligence AI
The global pharmaceutical industry is currently facing many wide ranging challenges including an aging population increased life expectancy a rise in chronic conditions reduced funding for treatments reduced numbers of clinical staff the ever increasing cost of drug development and raw materials and supply chain issues
EBR systems are more reliable and compliance than traditional paper documents log in measures